Management
Executive Committee
Scientific officers
CEA Paris-Saclay– MIRCen, Scientific Director
Pitié salpétriere Hospital– ICM, Deputy Scientific Director
Operational Management
CEA Paris-Saclay, Executive Director
Pitié salpétriere Hospital– ICM, General Secretary
CEA Paris-Saclay, Project Manager
CEA Paris-Saclay, Partnership Development Officer
Representative of partner organizations
CEA Paris-Saclay – MIRCen
Henri Mondor Hospital – UPEC
Robert-Debré Hospital – NeuroDiderot
Pitié-Salpêtrière Hospital – ICM
Bicêtre Hospital – N-BIPS
Oniris Nantes – INRAE
Scientific Coordination of research programs
Cell therapy : Dr. Anselme Perrier and Pr. Anne-Catherine Bachoud-Levi
Gene therapy : Pr. Marie-Anne Colle and Pr. Pierre Bougnères
In vivo assessment and therapeutic efficacy : Dr. Philippe Hantraye and Pr. Philippe Rémy
Drug therapies : Dr. Brahim Nait-Oumesmar and Pr. Bernard Zalc
Gene therapy : Pr. Marie-Anne Colle and Pr. Pierre Bougnères
In vivo assessment and therapeutic efficacy : Dr. Philippe Hantraye and Pr. Philippe Rémy
Drug therapies : Dr. Brahim Nait-Oumesmar and Pr. Bernard Zalc
Steering Committee
Elsa Cortijo – Director of fundamental research division, CEA
Alexis Brice – General Director, ICM
Valérie Thibaudeau - Infrastructures clusters – General Secretary, Inserm
Jean-Luc Dubois-Randé - President, UPEC
Emmanuelle Chevassus-Lozza - President, INRAE Angers-Nantes
Stéphanie Decoopman - Director of clinical research and innovation, AP-HP
Alexis Brice – General Director, ICM
Valérie Thibaudeau - Infrastructures clusters – General Secretary, Inserm
Jean-Luc Dubois-Randé - President, UPEC
Emmanuelle Chevassus-Lozza - President, INRAE Angers-Nantes
Stéphanie Decoopman - Director of clinical research and innovation, AP-HP
Scientific Advisory Board
Pr. Steve Dunnett : Neurobiologist– Cardiff University, Celle therapy specialist for neurodegenerative diseases (Parkinson, Huntington)
M. Anton Ussi : Operations and finance Director, ERIC EATRIS
Pr. Petra S. Huppi : Clinician, Head of the Development and Growth Department of the University Hospitals of Geneva, specialist in neurodevelopment
Pr. Pierre Maquet : Clinician, Head of the Neurology Department at the University of Liege, FNRS Research Director at the Cyclotron Research Centre of the University of Liege, specialist in functional neuroimaging
Pr. Luc Pellerin : Professor of cell biology at the University of Poitiers, specialist in cerebral metabolism and neuron-astrocyte relations
Pr. Olivier Rascol : Clinician, Professor of clinical pharmacology at the Toulouse University Hospital, specialist in Parkinson's disease
Dr. Agnès Renard-Viard : President of the Association « Science Health Society »
Pr. Frank S Walsh : CEO Ossianix Inc. USA, Specialist in Neurodegenrative desorders
Pr. Frauke Zipp : Clinician, Director of of the department of Neurology at the Mainz University, Neuro-immunologist specialist.
M. Anton Ussi : Operations and finance Director, ERIC EATRIS
Pr. Petra S. Huppi : Clinician, Head of the Development and Growth Department of the University Hospitals of Geneva, specialist in neurodevelopment
Pr. Pierre Maquet : Clinician, Head of the Neurology Department at the University of Liege, FNRS Research Director at the Cyclotron Research Centre of the University of Liege, specialist in functional neuroimaging
Pr. Luc Pellerin : Professor of cell biology at the University of Poitiers, specialist in cerebral metabolism and neuron-astrocyte relations
Pr. Olivier Rascol : Clinician, Professor of clinical pharmacology at the Toulouse University Hospital, specialist in Parkinson's disease
Dr. Agnès Renard-Viard : President of the Association « Science Health Society »
Pr. Frank S Walsh : CEO Ossianix Inc. USA, Specialist in Neurodegenrative desorders
Pr. Frauke Zipp : Clinician, Director of of the department of Neurology at the Mainz University, Neuro-immunologist specialist.